Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06427941
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-05-20
Brief Title:
A Phase 1 Study of BGB-B2033 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
Sponsor:
BeiGene
Organization:
BeiGene
Organization Data
Organization:
BeiGene
Class:
INDUSTRY
Study ID:
BGB-B2033-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BeiGene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None